Selected research
Market Outlook & Growth Opportunities
Global Gastrointestinal (GI) Stent Market Outlook and Growth Opportunities 2026
Market perspective
The global Gastrointestinal (GI) Stent market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Gastrointestinal (GI) Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Gastrointestinal (GI) Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Gastrointestinal (GI) Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Gastrointestinal (GI) Stent market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Gastrointestinal (GI) Stent market include C.R. Bard, ConMed, Cook Medical, ELLA-CS, Gore Medical, Hobbs Medical, Merit Endotek, Olympus America and Taewoong Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Gastrointestinal (GI) Stent market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Gastrointestinal (GI) Stent and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Gastrointestinal (GI) Stent sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gastrointestinal (GI) Stent market size, projected growth trends, production technologies, key applications, and end-use industries.
Gastrointestinal (GI) Stent Segment by Company
C.R. Bard
ConMed
Cook Medical
ELLA-CS
Gore Medical
Hobbs Medical
Merit Endotek
Olympus America
Taewoong Medical
Boston Scientific
Gastrointestinal (GI) Stent Segment by Type
Biliary Stents
Colonic Stents
Duodenal Stents
Esophageal Stents
Pancreatic Stents
Gastrointestinal (GI) Stent Segment by Application
Biliary Disease
Colorectal Cancer
Stomach Cancer
Gastrointestinal (GI) Stent Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Gastrointestinal (GI) Stent status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Gastrointestinal (GI) Stent market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Gastrointestinal (GI) Stent significant trends, drivers, influence factors in global and regions.
6. To analyze Gastrointestinal (GI) Stent competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gastrointestinal (GI) Stent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gastrointestinal (GI) Stent and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gastrointestinal (GI) Stent.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Gastrointestinal (GI) Stent market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gastrointestinal (GI) Stent industry.
Chapter 3: Detailed analysis of Gastrointestinal (GI) Stent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Gastrointestinal (GI) Stent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Gastrointestinal (GI) Stent in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Biliary Stents
- Colonic Stents
- Duodenal Stents
- Esophageal Stents
- Pancreatic Stents
Applications
- Biliary Disease
- Colorectal Cancer
- Stomach Cancer
Companies covered
- C.R. Bard
- ConMed
- Cook Medical
- ELLA-CS
- Gore Medical
- Hobbs Medical
- Merit Endotek
- Olympus America
- Taewoong Medical
- Boston Scientific
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Gastrointestinal (GI) Stent Sales Value (2021-2032)
- 1.2.2 Global Gastrointestinal (GI) Stent Sales Volume (2021-2032)
- 1.2.3 Global Gastrointestinal (GI) Stent Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Gastrointestinal (GI) Stent Market Dynamics
- 2.1 Gastrointestinal (GI) Stent Industry Trends
- 2.2 Gastrointestinal (GI) Stent Industry Drivers
- 2.3 Gastrointestinal (GI) Stent Industry Opportunities and Challenges
- 2.4 Gastrointestinal (GI) Stent Industry Restraints
3 Gastrointestinal (GI) Stent Market by Company
- 3.1 Global Gastrointestinal (GI) Stent Company Revenue Ranking in 2025
- 3.2 Global Gastrointestinal (GI) Stent Revenue by Company (2021-2026)
- 3.3 Global Gastrointestinal (GI) Stent Sales Volume by Company (2021-2026)
- 3.4 Global Gastrointestinal (GI) Stent Average Price by Company (2021-2026)
- 3.5 Global Gastrointestinal (GI) Stent Company Ranking (2024-2026)
- 3.6 Global Gastrointestinal (GI) Stent Company Manufacturing Base and Headquarters
- 3.7 Global Gastrointestinal (GI) Stent Company Product Type and Application
- 3.8 Global Gastrointestinal (GI) Stent Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Gastrointestinal (GI) Stent Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Gastrointestinal (GI) Stent Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Gastrointestinal (GI) Stent Market by Type
- 4.1 Gastrointestinal (GI) Stent Type Introduction
- 4.1.1 Biliary Stents
- 4.1.2 Colonic Stents
- 4.1.3 Duodenal Stents
- 4.1.4 Esophageal Stents
- 4.1.5 Pancreatic Stents
- 4.2 Global Gastrointestinal (GI) Stent Sales Volume by Type
- 4.2.1 Global Gastrointestinal (GI) Stent Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Gastrointestinal (GI) Stent Sales Volume by Type (2021-2032)
- 4.2.3 Global Gastrointestinal (GI) Stent Sales Volume Share by Type (2021-2032)
- 4.3 Global Gastrointestinal (GI) Stent Sales Value by Type
- 4.3.1 Global Gastrointestinal (GI) Stent Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Gastrointestinal (GI) Stent Sales Value by Type (2021-2032)
- 4.3.3 Global Gastrointestinal (GI) Stent Sales Value Share by Type (2021-2032)
5 Gastrointestinal (GI) Stent Market by Application
- 5.1 Gastrointestinal (GI) Stent Application Introduction
- 5.1.1 Biliary Disease
- 5.1.2 Colorectal Cancer
- 5.1.3 Stomach Cancer
- 5.2 Global Gastrointestinal (GI) Stent Sales Volume by Application
- 5.2.1 Global Gastrointestinal (GI) Stent Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Gastrointestinal (GI) Stent Sales Volume by Application (2021-2032)
- 5.2.3 Global Gastrointestinal (GI) Stent Sales Volume Share by Application (2021-2032)
- 5.3 Global Gastrointestinal (GI) Stent Sales Value by Application
- 5.3.1 Global Gastrointestinal (GI) Stent Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Gastrointestinal (GI) Stent Sales Value by Application (2021-2032)
- 5.3.3 Global Gastrointestinal (GI) Stent Sales Value Share by Application (2021-2032)
6 Gastrointestinal (GI) Stent Regional Sales and Value Analysis
- 6.1 Global Gastrointestinal (GI) Stent Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Gastrointestinal (GI) Stent Sales by Region (2021-2032)
- 6.2.1 Global Gastrointestinal (GI) Stent Sales by Region: 2021-2026
- 6.2.2 Global Gastrointestinal (GI) Stent Sales by Region (2027-2032)
- 6.3 Global Gastrointestinal (GI) Stent Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Gastrointestinal (GI) Stent Sales Value by Region (2021-2032)
- 6.4.1 Global Gastrointestinal (GI) Stent Sales Value by Region: 2021-2026
- 6.4.2 Global Gastrointestinal (GI) Stent Sales Value by Region (2027-2032)
- 6.5 Global Gastrointestinal (GI) Stent Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Gastrointestinal (GI) Stent Sales Value (2021-2032)
- 6.6.2 North America Gastrointestinal (GI) Stent Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Gastrointestinal (GI) Stent Sales Value (2021-2032)
- 6.7.2 Europe Gastrointestinal (GI) Stent Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Gastrointestinal (GI) Stent Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Gastrointestinal (GI) Stent Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Gastrointestinal (GI) Stent Sales Value (2021-2032)
- 6.9.2 South America Gastrointestinal (GI) Stent Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Gastrointestinal (GI) Stent Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Gastrointestinal (GI) Stent Sales Value Share by Country, 2025 VS 2032
7 Gastrointestinal (GI) Stent Country-level Sales and Value Analysis
- 7.1 Global Gastrointestinal (GI) Stent Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Gastrointestinal (GI) Stent Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Gastrointestinal (GI) Stent Sales by Country (2021-2032)
- 7.3.1 Global Gastrointestinal (GI) Stent Sales by Country (2021-2026)
- 7.3.2 Global Gastrointestinal (GI) Stent Sales by Country (2027-2032)
- 7.4 Global Gastrointestinal (GI) Stent Sales Value by Country (2021-2032)
- 7.4.1 Global Gastrointestinal (GI) Stent Sales Value by Country (2021-2026)
- 7.4.2 Global Gastrointestinal (GI) Stent Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Gastrointestinal (GI) Stent Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Gastrointestinal (GI) Stent Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Gastrointestinal (GI) Stent Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Gastrointestinal (GI) Stent Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Gastrointestinal (GI) Stent Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Gastrointestinal (GI) Stent Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Gastrointestinal (GI) Stent Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Gastrointestinal (GI) Stent Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Gastrointestinal (GI) Stent Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Gastrointestinal (GI) Stent Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Gastrointestinal (GI) Stent Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Gastrointestinal (GI) Stent Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Gastrointestinal (GI) Stent Sales Value Growth Rate (2021-2032)
- 7.9.2 France Gastrointestinal (GI) Stent Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Gastrointestinal (GI) Stent Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Gastrointestinal (GI) Stent Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Gastrointestinal (GI) Stent Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Gastrointestinal (GI) Stent Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Gastrointestinal (GI) Stent Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Gastrointestinal (GI) Stent Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Gastrointestinal (GI) Stent Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Gastrointestinal (GI) Stent Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Gastrointestinal (GI) Stent Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Gastrointestinal (GI) Stent Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Gastrointestinal (GI) Stent Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Gastrointestinal (GI) Stent Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Gastrointestinal (GI) Stent Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Gastrointestinal (GI) Stent Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Gastrointestinal (GI) Stent Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Gastrointestinal (GI) Stent Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Gastrointestinal (GI) Stent Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Gastrointestinal (GI) Stent Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Gastrointestinal (GI) Stent Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Gastrointestinal (GI) Stent Sales Value Growth Rate (2021-2032)
- 7.16.2 China Gastrointestinal (GI) Stent Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Gastrointestinal (GI) Stent Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Gastrointestinal (GI) Stent Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Gastrointestinal (GI) Stent Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Gastrointestinal (GI) Stent Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Gastrointestinal (GI) Stent Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Gastrointestinal (GI) Stent Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Gastrointestinal (GI) Stent Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Gastrointestinal (GI) Stent Sales Value Growth Rate (2021-2032)
- 7.19.2 India Gastrointestinal (GI) Stent Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Gastrointestinal (GI) Stent Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Gastrointestinal (GI) Stent Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Gastrointestinal (GI) Stent Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Gastrointestinal (GI) Stent Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Gastrointestinal (GI) Stent Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Gastrointestinal (GI) Stent Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Gastrointestinal (GI) Stent Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Gastrointestinal (GI) Stent Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Gastrointestinal (GI) Stent Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Gastrointestinal (GI) Stent Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Gastrointestinal (GI) Stent Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Gastrointestinal (GI) Stent Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Gastrointestinal (GI) Stent Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Gastrointestinal (GI) Stent Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Gastrointestinal (GI) Stent Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Gastrointestinal (GI) Stent Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Gastrointestinal (GI) Stent Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Gastrointestinal (GI) Stent Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Gastrointestinal (GI) Stent Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Gastrointestinal (GI) Stent Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Gastrointestinal (GI) Stent Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Gastrointestinal (GI) Stent Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Gastrointestinal (GI) Stent Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Gastrointestinal (GI) Stent Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Gastrointestinal (GI) Stent Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Gastrointestinal (GI) Stent Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Gastrointestinal (GI) Stent Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Gastrointestinal (GI) Stent Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Gastrointestinal (GI) Stent Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Gastrointestinal (GI) Stent Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Gastrointestinal (GI) Stent Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Gastrointestinal (GI) Stent Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Gastrointestinal (GI) Stent Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Gastrointestinal (GI) Stent Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Gastrointestinal (GI) Stent Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Gastrointestinal (GI) Stent Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Gastrointestinal (GI) Stent Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Gastrointestinal (GI) Stent Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Gastrointestinal (GI) Stent Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Gastrointestinal (GI) Stent Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 C.R. Bard
- 8.1.1 C.R. Bard Company Information
- 8.1.2 C.R. Bard Business Overview
- 8.1.3 C.R. Bard Gastrointestinal (GI) Stent Sales, Value and Gross Margin (2021-2026)
- 8.1.4 C.R. Bard Gastrointestinal (GI) Stent Product Portfolio
- 8.1.5 C.R. Bard Recent Developments
- 8.2 ConMed
- 8.2.1 ConMed Company Information
- 8.2.2 ConMed Business Overview
- 8.2.3 ConMed Gastrointestinal (GI) Stent Sales, Value and Gross Margin (2021-2026)
- 8.2.4 ConMed Gastrointestinal (GI) Stent Product Portfolio
- 8.2.5 ConMed Recent Developments
- 8.3 Cook Medical
- 8.3.1 Cook Medical Company Information
- 8.3.2 Cook Medical Business Overview
- 8.3.3 Cook Medical Gastrointestinal (GI) Stent Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Cook Medical Gastrointestinal (GI) Stent Product Portfolio
- 8.3.5 Cook Medical Recent Developments
- 8.4 ELLA-CS
- 8.4.1 ELLA-CS Company Information
- 8.4.2 ELLA-CS Business Overview
- 8.4.3 ELLA-CS Gastrointestinal (GI) Stent Sales, Value and Gross Margin (2021-2026)
- 8.4.4 ELLA-CS Gastrointestinal (GI) Stent Product Portfolio
- 8.4.5 ELLA-CS Recent Developments
- 8.5 Gore Medical
- 8.5.1 Gore Medical Company Information
- 8.5.2 Gore Medical Business Overview
- 8.5.3 Gore Medical Gastrointestinal (GI) Stent Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Gore Medical Gastrointestinal (GI) Stent Product Portfolio
- 8.5.5 Gore Medical Recent Developments
- 8.6 Hobbs Medical
- 8.6.1 Hobbs Medical Company Information
- 8.6.2 Hobbs Medical Business Overview
- 8.6.3 Hobbs Medical Gastrointestinal (GI) Stent Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Hobbs Medical Gastrointestinal (GI) Stent Product Portfolio
- 8.6.5 Hobbs Medical Recent Developments
- 8.7 Merit Endotek
- 8.7.1 Merit Endotek Company Information
- 8.7.2 Merit Endotek Business Overview
- 8.7.3 Merit Endotek Gastrointestinal (GI) Stent Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Merit Endotek Gastrointestinal (GI) Stent Product Portfolio
- 8.7.5 Merit Endotek Recent Developments
- 8.8 Olympus America
- 8.8.1 Olympus America Company Information
- 8.8.2 Olympus America Business Overview
- 8.8.3 Olympus America Gastrointestinal (GI) Stent Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Olympus America Gastrointestinal (GI) Stent Product Portfolio
- 8.8.5 Olympus America Recent Developments
- 8.9 Taewoong Medical
- 8.9.1 Taewoong Medical Company Information
- 8.9.2 Taewoong Medical Business Overview
- 8.9.3 Taewoong Medical Gastrointestinal (GI) Stent Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Taewoong Medical Gastrointestinal (GI) Stent Product Portfolio
- 8.9.5 Taewoong Medical Recent Developments
- 8.10 Boston Scientific
- 8.10.1 Boston Scientific Company Information
- 8.10.2 Boston Scientific Business Overview
- 8.10.3 Boston Scientific Gastrointestinal (GI) Stent Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Boston Scientific Gastrointestinal (GI) Stent Product Portfolio
- 8.10.5 Boston Scientific Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Gastrointestinal (GI) Stent Value Chain Analysis
- 9.1.1 Gastrointestinal (GI) Stent Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Gastrointestinal (GI) Stent Sales Mode & Process
- 9.2 Gastrointestinal (GI) Stent Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Gastrointestinal (GI) Stent Distributors
- 9.2.3 Gastrointestinal (GI) Stent Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst